GRIFOLS, S.A. guarantees that the texts published in this page correspond exactly and entirely with the texts sent to the CNMV by the Company or by third parties. All the communications are available in the Web page of the CNMV.
October 26, 2021 Grifols earns approval for the voluntary public tender offer of Biotest
September 17, 2021 Grifols acquires Tiancheng Pharmaceutical Holding, the largest shareholder of Biotest
September 17, 2021 Presentation of Grifols' investment in Biotest and call details to analysts and investors